The administration criteria and the way of administration did
not modify the effectiveness and the security of the AHC
M.A. Gomez, E.
Barranco, E. Pérez Campos
Board of Directors of Spanish Society of
Contraception, Madrid, Spain
Objective, design and method The statement
indicated as the title of the poster was one of the most important conclusions
of the Conference of Consent carried out by the SEC in November 2005.
Conclusions Neither the criteria (daily, weekly, monthly, quarterly, …) nor
the way of administration (oral, percutaneous, intramuscular, vaginal, …)
build up factors that modify the results of the treatment with AHC, evaluating
the efficiency and the security of the same. According to the available
scientific evidence, none of the ways and none of the criteria improve the
results of the alternative options. The “studies” that voucher the
contrary either are of very low quality or are directly promoted by the
pharmaceutical industry. None of the criteria and none of the ways are of
high-priority clinical indication.
Also, in view of the scientific evidence, it
can be asserted that the changes in the menstrual cycle induced by the
contraceptive criteria lack any negative repercussions on the women’s health.